Publications by authors named "J E Sasaki"

Introduction And Importance: Fallopian tube cancer, particularly the carcinosarcoma subtype, is a rare malignancy posing diagnostic challenges.

Case Presentation: Our patient was an 83-year-old, nulligravida woman, presented to our outpatient clinic with one month of pelvic pain. On examination, a pelvic mass was detected.

View Article and Find Full Text PDF

In mammals, SOX9/Sox9 expression in embryonic gonads is essential for male gonadal sex determination. Multiple enhancers of Sox9 have been identified, of which the mXYSRa/Enh13 enhancer plays a crucial role in mice. SOX9 and SRY binding sites within the enhancer have been identified as functional.

View Article and Find Full Text PDF

Introduction: Osimertinib is the first-line treatment for patients with NSCLC who have EGFR mutations and favorable performance status (PS). Despite the increasing clinical data on osimertinib, evidence for its use in patients with impaired PS remains limited. Therefore, a multicenter phase II trial (OPEN/TORG2040) was conducted to evaluate the efficacy and safety of first-line osimertinib treatment in patients with EGFR mutation-positive NSCLC and a poor PS.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed outcomes for pediatric patients with blunt liver and spleen injuries (BLSI) treated at hospitals with and without pediatric intensive care units (PICUs) between 2008 and 2019.
  • Among the 1401 patients, 30-day mortality rates were lower in hospitals with PICUs (0.7%) compared to those without (1.3%), and also compared to adult ICUs.
  • Overall, while adverse events were infrequent, the findings suggested that treatment in hospitals with PICUs may lead to better outcomes for pediatric patients with BLSI.
View Article and Find Full Text PDF

Purpose: In laparoscopic inguinal hernia surgery, proper recognition of loose connective tissue, nerves, vas deferens, and microvessels is important to prevent postoperative complications, such as recurrence, pain, sexual dysfunction, and bleeding. EUREKA (Anaut Inc., Tokyo, Japan) is a system that uses artificial intelligence (AI) for anatomical recognition.

View Article and Find Full Text PDF